News
-
-
-
PRESS RELEASE
Xenetic Biosciences, Inc. Enters into Materials Transfer Agreement with Tokyo Medical University for the Advancement of Its DNase-Based Oncology Platform
Xenetic partners with Tokyo Medical University to evaluate recombinant DNase I for Ewing sarcoma treatment in preclinical model. Agreement enhances DNase program development -
-
PRESS RELEASE
Original-Research: Deutsche Effecten- und Wechsel- Beteiligungsgesellschaft AG (von First Berlin Equity Research GmbH): Buy
First Berlin Equity Research updates recommendation on Deutsche Effecten- und Wechsel-Beteiligungsgesellschaft AG to Buy with a decreased target price of €1.50. Company's financials for H1/24 in line with expectations. Management actively seeking exit options -
PRESS RELEASE
GameSquare Announces Preliminary Third Quarter 2024 Results and Provides Business Update
GameSquare Holdings, Inc. expects stellar Q3 results, with revenue estimated to surpass $26.5 million. The company raises its 2024 proforma revenue guidance to $105-110 million due to strong performance -
PRESS RELEASE
Plantd Signs Multi-Year Contract With D.R. Horton for 10 Million Carbon-Negative Building Panels
Plantd partners with D.R. Horton to supply 10 million carbon-negative structural panels made from fast-growing grass, reducing CO2 emissions and supporting sustainable homebuilding practices -
-
-
